3-(1H-INDOLE-2-CARBONYL)-6,6-DIMETHYL-N-((S)-1-OXO-3-((S)-2-OXOPYRROLIDIN-3-YL)P ROPAN-2-YL)-3-AZABICYCLO[3.1.0]HEXANE-2-CARBOXAMIDE DERIVATIVES AS MPRO INHIBITORS FOR THE TREATMENT OF CORONAVIRUS INFECTIONS
Publication
EP4587433A1
Kind: A1
Mar 18, 2026
Applicants
Takeda Pharmaceutical Company Limited, Schrödinger, Inc.
Inventors
CARNEY, Daniel, CHANG, Edcon, KOMANDLA, Mallareddy, FRYE, Leah L., LEFFLER, Abba
IPC Classifications
C07D 403/12 20060101AFI20240322BHEP
C07D 403/14 20060101ALI20240322BHEP
C07D 401/14 20060101ALI20240322BHEP
C07D 491/04 20060101ALI20240322BHEP
C07D 471/04 20060101ALI20240322BHEP
A61K 31/4025 20060101ALI20240322BHEP
A61K 31/403 20060101ALI20240322BHEP
A61K 31/404 20060101ALI20240322BHEP
A61K 31/407 20060101ALI20240322BHEP
A61P 31/12 20060101ALI20240322BHEP
A61P 31/14 20060101ALI20240322BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR